博雅生物(300294.SZ):獲批設置單採血漿站
格隆匯12月10日丨博雅生物(300294.SZ)公佈,公司於2021年12月10日收到山西省衞生健康委員會下發的《設置單採血漿站批准書》(晉衞審批設[2021]02號),山西省衞生健康委員會同意公司按照下列事項設置單採血漿有限公司(單採血漿站):
機構類別:單採血漿有限公司(單採血漿站)
機構名稱:陽城縣博雅單採血漿有限公司
機構選址:陽城縣
業務範圍:血液製品生產用人血漿
採漿區域:陽城縣
本批准書有效期至2023年12月09日
公司將按照《血液製品管理條例》和《單採血漿站管理辦法》等有關規定,儘快完成該單採血漿站的建設及相關執業許可手續的辦理。該單採血漿站建成並通過驗收後,將有利於提升公司原料血漿供應能力,提高公司盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.